Anticancer Agent “TASFYGO Tablets 35mg” (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Most cancers with FGFR2 Gene Fusion or Rearrangements By Investing.com
TOKYO, Nov 20, 2024 - (JCN Newswire) - - Eisai Co., Ltd.…
Breakthrough Remedy designation for Sanbexin sublingual tablets granted by the US Meals and Drug Administration By Investing.com
NANJING, China, Sept. 14, 2024 /PRNewswire/ -- On September 2, 2024, Simcere…
